Cortese, K.; Ponassi, M.; Profumo, A.; Coronel Vargas, G.; Iervasi, E.; Gagliani, M.C.; Bellese, G.; Tavella, S.; Castagnola, P.
Lipid Metabolism Reprogramming and Trastuzumab Resistance in Breast Cancer Cell Lines Overexpressing the ERBB2 Membrane Receptor. Membranes 2023, 13, 540.
https://doi.org/10.3390/membranes13060540
AMA Style
Cortese K, Ponassi M, Profumo A, Coronel Vargas G, Iervasi E, Gagliani MC, Bellese G, Tavella S, Castagnola P.
Lipid Metabolism Reprogramming and Trastuzumab Resistance in Breast Cancer Cell Lines Overexpressing the ERBB2 Membrane Receptor. Membranes. 2023; 13(6):540.
https://doi.org/10.3390/membranes13060540
Chicago/Turabian Style
Cortese, Katia, Marco Ponassi, Aldo Profumo, Gabriela Coronel Vargas, Erika Iervasi, Maria Cristina Gagliani, Grazia Bellese, Sara Tavella, and Patrizio Castagnola.
2023. "Lipid Metabolism Reprogramming and Trastuzumab Resistance in Breast Cancer Cell Lines Overexpressing the ERBB2 Membrane Receptor" Membranes 13, no. 6: 540.
https://doi.org/10.3390/membranes13060540
APA Style
Cortese, K., Ponassi, M., Profumo, A., Coronel Vargas, G., Iervasi, E., Gagliani, M. C., Bellese, G., Tavella, S., & Castagnola, P.
(2023). Lipid Metabolism Reprogramming and Trastuzumab Resistance in Breast Cancer Cell Lines Overexpressing the ERBB2 Membrane Receptor. Membranes, 13(6), 540.
https://doi.org/10.3390/membranes13060540